fda warning letter hims & hers compounded semaglutide september 2025 Health stock tanks after says competitor Eli Lilly's weight-loss drug shortage is over Hims & Hers Health addresses
Description
NTS GLP-1R neurons, sensitive to nutritive stimuli, induced satiety without aversion, whereas AP GLP-1R neurons elicited strong nausea-like behavior in mice
Key Findings: Most common: Nausea (43%), diarrhea (33%), vomiting (21%) Unique to retatrutide: Dysesthesia (20.9% @ 12mg in TRIUMPH-4, 8.8% @ 9mg) Discontinuation rate: 18.2% in TRIUMPH-4, 11.3% in TRIUMPH-1 (general obesity population) compared to semaglutide 6.9%, tirzepatide 6.2% Good news: Most side effects peak during dose escalation and improve significantly after week 16 Management: Slow titration, dietary modifications, and proper timing dramatically reduce severity Understanding the Three Categories of Side Effects 1
Working with PlexusDx providers helps account for these variables and adjust expectations realistically
GLP-1 medications like Ozempic and Wegovy are helping millions of people lose weight and improve their health
She quickly realized there was much more to these medications than weight loss alone
Originally developed to help people with type 2 diabetes , researchers noticed a significant side effect during trials: weight loss
